CSL (OTCPK:CSLL.Y) 2025 Capital Markets Day November 04, 2025 07:00 PM ET Company ParticipantsDave Ross - CEOPaul Perreault - CEONoneThank you, Fiona.Paul PerreaultThank you, Fiona. Good evening, everyone, and good morning to those online. It's great to see everyone here in the beautiful city of Chicago. I ran into Paul in the elevator. I was surprised how great the weather is here. But I know many of you traveled a long distance to be with us here today, and we certainly appreciate that, and we want to ack ...

Immune response successfully improved with second generation vaccine candidate Saint-Herblain (France), November 4, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive results of its Phase 1 clinical trial investigating the safety and immunogenicity of VLA1601, its second-generation adjuvanted inactivated vaccine candidate against the Zika virus (ZIKV). The randomized controlled Phase 1 trial, VLA1601-102, enrolled approximately 150 participants aged ...

财报季概览 - 超过1600家公司计划在本周公布财报 [1] 周一财报焦点 - Palantir Technologies Inc (PLTR) 将于周一盘后公布第三季度财报，分析师预期每股收益0.17美元，营收10.9亿美元，同比分别增长近50%和70% [2] - 业绩预期反映人工智能平台需求的强劲势头，但由于公司估值较高，股价可能出现波动 [3] 周二财报焦点 - Advanced Micro Devices Inc (AMD) 和 Super Micro Computer Inc (SMCI) 两大科技公司将于周二盘后公布财报 [3] - 其他周二盘后公布财报的公司包括 Marathon Digital Holdings Inc (MARA)、FuboTV Inc (FUBO)、BioCryst Pharmaceuticals Inc (BCRX)、TG Therapeutics Inc (TGTX)、Cipher Mining Inc (CIFR)、ON Semiconductor Corp (ON) 等 [4][5] - 周二盘后公布财报的公司还包括 Hims & Hers Health Inc (HIMS)、Sarepta Therapeutics Inc (SRPT)、Realty Income Corp (O)、Navitas Semiconductor Corp (NVTS) 等 [6] - 周二盘后公布财报的公司还包括 SNDL Inc (SNDL)、Shopify Inc (SHOP)、Uber Technologies Inc (UBER)、Pfizer Inc (PFE)、Spotify Technology SA (SPOT) 等 [7] 周三财报焦点 - 快餐巨头 McDonald's Corp (MCD) 将于周三盘前公布财报，分析师预期每股收益3.33美元，营收70.9亿美元 [8] - 投资者关注由价值导向促销活动驱动的销售增长以及关于消费者支出趋势的评论 [8] - 热门零售经纪商 Robinhood Markets Inc (HOOD) 将于周三盘后公布财报，预期第三季度每股收益0.51美元，营收11.9亿美元，同比分别增长200%和90% [9] - Robinhood的增长动力来自创纪录的交易和加密货币活动 [9] 周四财报焦点 - 两大疫苗制造商 Moderna Inc (MRNA) 和 Novavax Inc (NVAX) 将于周四盘前公布财报 [10] - 新晋网红股 Opendoor Technologies Inc (OPEN) 将于周四盘后公布财报，投资者将关注其面向零售投资者的直播视频财报电话会议 [10] - 周四盘后公布财报的公司包括 Beyond Meat Inc (BYND)、Clover Health Investments Corp (CLOV)、Rivian Automotive Inc (RIVN)、Upstart Holdings Inc (UPST)、Pinterest Inc (PINS) 等 [11] - 周四盘后公布财报的公司还包括 Aurora Cannabis Inc (ACB)、Unity Software Inc (U)、Lemonade Inc (LMND) 等 [12] - 周四盘后公布财报的公司还包括 AMC Entertainment Holdings Inc (AMC)、Snap Inc (SNAP)、Lucid Group Inc (LCID)、Qualcomm Inc (QCOM)、IonQ Inc (IONQ)、Lyft Inc (LYFT)、Fastly Inc (FSLY)、ARM Holdings Plc (ARM)、Joby Aviation Inc (JOBY)、Zevra Therapeutics Inc (ZVRA) 等 [13] - 周四盘后公布财报的公司还包括 Cronos Group Inc (CRON)、D-Wave Quantum Inc (QBTS)、Under Armour Inc (UAA) 等 [14] 周五财报焦点 - 两大能源公司 Constellation Energy Corp (CEG) 和 Duke Energy Corp (DUK) 将于周五盘前公布财报 [15] - 周五盘前公布财报的公司还包括 Block Inc (XYZ)、DraftKings Inc (DKNG)、GoPro Inc (GPRO)、SoundHound AI Inc (SOUN)、Peloton Interactive Inc (PTON)、Airbnb Inc (ABNB)、Blink Charging Co (BLNK)、Trade Desk Inc (TTD) 等 [18] - 周五盘前公布财报的公司还包括 Canopy Growth Corp (CGC)、Enbridge Inc (ENB)、Wendy's Co (WEN) 等 [19]

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for acute myeloid leukemiaNew data showing EVX-04 induces strong T-cell responses and cancer cell killing will be presented at an oral session at the American Society of Hematology (ASH) Annual Meeting and Exposition in Florida on December 6, 2025The concept behind EVX-04 is broadly applicable with pot ...

文章核心观点 - 公司发布关于HERA框架协议和公共准备业务的澄清说明，确认了来自欧洲卫生应急准备与响应管理局的75万剂MVA-BN天花/猴痘疫苗订单，该订单将于2026年交付，并与早前美国生物医学高级研究与发展管理局的订单共同为2026年构建15-20亿丹麦克朗的基础准备业务奠定基础 [1][2] 新订单详情 - 欧洲委员会通过HERA下达了75万剂MVA-BN天花/猴痘疫苗的初始订单，将于2026年交付 [2] - 这是公司为2026年获得的第二份订单，第一份是2024年5月宣布的美国BARDA的合同选项 [2] - 公司预期在接下来一年内将获得额外的MVA-BN订单 [2] 财务影响与业务展望 - BARDA和HERA的订单是构建2026年基础准备业务的良好开端，规模预计在15-20亿丹麦克朗，与此前指引一致 [2] - HERA协议的授予不影响2025年的业绩指引 [2] 公司业务定位 - 公司是一家全球疫苗公司，致力于通过创新疫苗改善健康并拯救生命 [3] - 公司是政府加强公共卫生准备的首选天花和猴痘疫苗供应商，并拥有领先的旅行疫苗组合 [3]

COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025. About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to government ...

Saint-Herblain (France), October 27, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe. Valneva will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, primarily the upcoming Phase 3 trial outcomes for VLA15, the Company’s Lyme dis ...

要约收购核心动态 - 由Nordic Capital Fund XI和Permira管理的基金控制的Innosera ApS对Bavarian Nordic发起自愿公开要约收购 [1] - 收购要约的要约期已延长且要约价格已提高 [2] - 公司董事会一致决定重申其建议，推荐股东接受此收购要约 [2][3] 董事会立场与评估 - 董事会主席Luc Debruyne表示，基于对公司基本价值的评估以及在财团收购要约公开前较长时期内的股价水平，董事会认为经提高后的要约价格公平且具有吸引力 [2] - 董事会认为此次收购对股东而言是公平且具有吸引力的 [2] 文件发布与获取 - 包括董事会声明在内的要约相关文件可在公司网站www.bavarian-nordic.com获取 [4] - 公司已发布丹麦语原文的补充董事会声明及其英文翻译版，若存在差异，以丹麦语版本为准 [5][6] 公司背景信息 - Bavarian Nordic是一家全球疫苗公司，致力于通过创新疫苗改善健康并拯救生命 [7] - 公司是政府机构天花和猴痘疫苗的首选供应商，并拥有领先的旅行疫苗组合 [7]

Bavarian Nordic said on Wednesday a consortium led by Nordic Capital and Permira has raised its offer price for the vaccine maker to 250 Danish crowns ($38.94) after its initial bid was not accepted b... ...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, October 15, 2025 – With reference to the announcement of 26 August 2025 (no. 24/2025) regarding the publication of the offer document (the "Offer Document") concerning the all-cash voluntary recommended public takeover offer to acquire all of the issued and outstanding shares (except treasury ...